References

1. 1.
   China Anti-Cancer Association Committee of Rehabilitation and Palliative Care，Chinese Society of Clinical Oncology Committee of Tumor Support and Rehabilitation Care.Chinese expert consensus on diagnosis and treatment of cancer-related fatigue［J］.Nat Med J China，2022，102（3）：180-189.
2. 2.
   MA Y，HE B，JIANG M，et al.Prevalence and risk factors of cancer-related fatigue：A systematic review and meta-analysis［J］.Int J Nurs Stud，2020，111：103707.
3. 3.
   BEHRINGER K，GOERGEN H，MÜLLER H，et al.Cancer-related fatigue in patients with and survivors of hodgkin lymphoma：The impact on treatment outcome and social reintegration［J］.J Clin Oncol，2016，34 （36）：4329-4337.
4. 4.
   GROENVOLD M，PETERSEN M A，IDLER E，et al.Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients［J］.Breast Cancer Res Treat，2007，105 （2）：209-219.
5. 5.
   ADAM S，VAN DE POLL-FRANSE L V，MOLS F，et al.The association of cancer-related fatigue with all-cause mortality of colorectal and endometrial cancer survivors：Results from the population-based PROFILES registry［J］.Cancer Med，2019，8 （6）：3227-3236.
6. 6.
   MUSTIAN K M，ALFANO C M，HECKLER C，et al.Comparison of pharmaceutical，psychological，and exercise treatments for cancer-related fatigue：A Meta-analysis［J］.JAMA Oncol，2017，3 （7）：961-968.
7. 7.
   XU J L，LU W M，XU D H.Effect of SQYZ decoction combined with Tegio and Oxaliplatin chemotherapy on the short-term efficacy and clinical benefits of patients with advanced gastric cancer［J］.Liaoning J Tradit Chin Med，2018，45（11）：2325-2327.
8. 8.
   XU J L，YU W，CHENG L L，et al.Effect of SQYZ decoction combined with chemotherapy on long-term efficacy of advanced gastric cancer［J］.World J Integr Tradit West Med，2022，17（7）：1380-1383.
9. 9.
   GLUBA-BRZÓZKA A，FRANCZYK B，OLSZEWSKI R，et al.The influence of inflammation on anemia in CKD patients［J］.Int J Mol Sci，2020，21 （3）：725.
10. 10.
    SONTI G，ILYIN S E，PLATA-SALAMáN C R.Anorexia induced by cytokine interactions at pathophysiological concentrations［J］.Am J Physiol，1996，270 （6 Pt 2）：R1394-1402.
11. 11.
    XU Y，WANG X S，CHEN Y，et al.A phase Ⅱ randomized controlled trial of Renshen Yangrong Tang herbal extract granules for fatigue reduction in cancer survivors［J］.J Pain Symptom Manage，2020，59 （5）：966-973.
12. 12.
    CHEN L L，ZHANG A R，BU W L，et.al.Meta-anaiysis of effectiveness and safety of traditional Chinese medicine in the treatment of cancer-related fatigue after chmotherapy［J］.Yunnan J Tradit Chin Med Mater Med，2024，45（5）：31-39.
13. 13.
    DENG W，HE J.Clinical trial design and statistical analysis［M］.Beijing：People's Health Publishing House，2012：127-128.
14. 14.
    IN H，SOLSKY I，PALIS B，et al.Validation of the 8^th edition of the AJCC TNM staging system for gastric cancer using the national cancer database［J］.Ann Surg Oncol，2017，24 （12）：3683-3691.
15. 15.
    PORTENOY R K，ITRI L M.Cancer-related fatigue：Guidelines for evaluation and management［J］.Oncologist，1999，4 （1）：1-10.
16. 16.
    XU B，WANG X，WANG H，et al.Efficacy and safety of herbal formulas with the function of gut microbiota regulation for gastric and colorectal cancer：A systematic review and Meta-analysis［J］.Front Cell Infect Microbiol，2022，12：875225.
17. 17.
    PETERSEN M A，AARONSON N K，ARRARAS J I，et al.The EORTC CAT core-The computer adaptive version of the EORTC QLQ-C30 questionnaire［J］.Eur J Cancer，2018，100：8-16.
18. 18.
    ZHENG X Y.Guidelines for clinical research of traditional Chinese medicine［M］.Beijing：China Medical Science Press，2002：361-363.
19. 19.
    BOWER J E，GANZ P A，IRWIN M R，et.al.Type I interferons，inflammation，and fatigue in a longitudinal RNA study of women with breast cancer［J］.Brain Behav Immun，2024，118：312-317.
20. 20.
    SAQUETTO M B，MACHADO R M，BOMFIM I，et al.Combined exercise on fatigue，quality of life and physical functioning in people under chemotherapy with oxaliplatin：Systematic review and Meta-analysis［J］.J Bodyw Mov Ther，2024，39：654-665.
21. 21.
    PRIGOZIN A，UZIELY B，MUSGRAVE C F，et al.The relationship between symptom severity and symptom interference，education，age，marital status，and type of chemotherapy treatment in Israeli women with early-stage breast cancer［J］.Oncol Nurs Forum，2010，37，411-418.
22. 22.
    YIN Y J，CHANG L P，WEI C.Theoretical exploration of cancer-related fatigue in malignant tumors guided by luobing theory［J］.Chin J Exper Tradit Med Form，2024，30（6）：211-217.
23. 23.
    YANG W J，DAI A W，ZOU X，et.al.Professor LIU Shenlin's experience in treating advanced gastric cancer［J］.Mod Chin Clin Med，2023，30（3）：113-116.
24. 24.
    ZENG S，YU Z，XU X，et al.Identification of the active constituents and significant pathways of Shen-Qi-Yi-Zhu decoction on antigastric cancer：A network pharmacology research and experimental validation［J］.Evid Based Complement Alternat Med，2021，2021：6642171.
25. 25.
    YANG J Y，XIE J C，MA X C，et，al.Regulation of signaling pathways associated with gastric cancer by Chinese medicine：A review［J］.Chin J Exp Tradit Med Form，2023，29（16）：217-228.
26. 26.
    REYES-GIBBY C C，SHETE S，YENNURAJALINGAM S，et al.Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas：Assessing the influence of cytokine genes［J］.J Pain Symptom Manage，2009，38 （6）：894-902.
27. 27.
    REYES-GIBBY C C，WANG J，SPITZ M.Genetic variations in interleukin-8 and interleukin-10 are associated with pain，depressed mood，and fatigue in lung cancer patients［J］.J Pain Symptom Manage，2013，46（2）：161-172.
28. 28.
    CLEELAND C S，BENNETT G J，DANTZER R，et al.Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism？ A cytokine-immunologic model of cancer symptoms［J］.Cancer，2003，97 （11）：2919-2925.
29. 29.
    MONK J P，PHILLIPS G，WAITE R，et al.Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients［J］.J Clin Oncol，2006，24（12）：1852-1859.